Vitamin D and multiple sclerosis: Epidemiology, immunology, and genetics

Current Opinion in Neurology

Volumn 25, Issue 3, 2012, Pages 246-251

  Simon, Kelly C ^a,b   Munger, Kassandra L ^a   Ascherio, Alberto ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Epidemiology; Multiple sclerosis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; BETA1A INTERFERON; ERGOCALCIFEROL; INTERLEUKIN 17; VITAMIN D; VITAMIN D RECEPTOR;

CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EPSTEIN BARR VIRUS; GENE MUTATION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; META ANALYSIS (TOPIC); MULTIPLE SCLEROSIS; REGULATORY T LYMPHOCYTE; RELAPSE; REVIEW; RISK FACTOR; TH1 TH2 BALANCE; ULTRAVIOLET B RADIATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; DISEASE PROGRESSION; HUMANS; MULTIPLE SCLEROSIS; RISK FACTORS; VITAMIN D;

EID: 84860735624     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e3283533a7e     Document Type: Review

References (48)

1. Goldberg P. Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence (A viewpoint) Part 1: Sunlight, dietary factors and epidemiology. Int J Environ Stud 1974; 6:19-27.
2. Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 1995; 61 (Suppl):638S-645S.
3. Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol 2010; 9:599-612.
4. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296:2832-2838.
5. Banwell B, Bar-Or A, Arnold DL, et al. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol 2011; 10:436-445.
6. Becklund BR, Severson KS, Vang SV, Deluca HF. UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production. Proc Natl Acad Sci USA 2010; 107:6418-6423.
7. Lucas RM, Ponsonby AL, Dear K, et al. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 2011; 76:540-548.
8. Ascherio A, Munger KL, Giovannucci E, et al. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 2011; 77:1405-1406.
9. Handel AE, Giovannoni G, Ebers GC, Ramagopalan SV. Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol 2010; 6:156-166.
10. Mirzaei F, Michels KB, Munger K, et al. Gestational vitamin D and the risk of multiple sclerosis in offspring. Ann Neurol 2011; 70:30-40.
11. Munger KL, Chitnis T, Frazier AL, et al. Dietary intake of vitamin D during adolescence and risk of multiple sclerosis. J Neurol 2011; 258:479-485.
12. O'Connor K, Weinstock-Guttman B, Carl E, et al. Patterns of dietary and herbal supplement use by multiple sclerosis patients. J Neurol 2011. doi:10.1007/s00415-011-6226-3. [Epub ahead of print]
13. Looker AC, Pfeiffer CM, Lacher DA, et al. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008; 88:1519-1527.
14. Gelfand JM, Cree BA, McElroy J, et al. Vitamin D in African Americans with multiple sclerosis. Neurology 2011; 76:1824-1830.
15. Weinstock-Guttman B, Zivadinov R, Qu J, et al. Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients. J Neurol Neurosurg Psychiatry 2011; 82:189-195.
16. Mowry EM, Krupp LB, Milazzo M, et al. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol 2010; 67:618-624.
17. Simpson S Jr, Taylor B, Blizzard L, et al. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol 2010; 68:193-203.
18. Stein MS, Liu Y, Gray OM, et al. A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology 2011; 77:1611-1618.
19. Munger KL, Ascherio A. Prevention and treatment of MS: studying the effects of vitamin D. Mult Scler 2011; 17:1405-1411.
20. Smolders J, Hupperts R, Barkhof F, et al. Efficacy of vitamin D(3) as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: a phase II, multicenter, double-blind, randomized, placebo-controlled trial. J Neurol Sci 2011; 311:44-49.
21. Uitterlinden AG, Fang Y, Van Meurs JB, et al. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004; 338:143-156.
22. Huang J, Xie ZF. Polymorphisms in the vitamin D receptor gene and multiple sclerosis risk: A meta-analysis of case-control studies. J Neurol Sci 2012; 313:79-85.
23. Cox MB, Ban M, Bowden NA, et al. Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis. Mult Scler 2012; 18:16-22.
24. Patsopoulos NA, de Bakker PI. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol 2011; 70:897-912.
25. Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010; 376:180-188.
26. Ahn J, Stolzenberg-Solomon R, Simon K, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 2010; 19:2739-2745.
27. Orton SM, Ramagopalan SV, Para AE, et al. Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians. J Neurol Sci 2011; 305:116-120.
28. Simon KC, Munger KL, Kraft P, et al. Genetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis. J Neurol 2011; 258:1676-1682.
29. Alloza I, Otaegui D, de Lapuente AL, et al. ANKRD55 and DHCR7 are novel multiple sclerosis risk loci. Genes Immun 2011. doi:10.1038/gene.2011.81. [Epub ahead of print]
30. Cooper JD, Smyth DJ, Walker NM, et al. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 2011; 60:1624-1631.
31. Ramagopalan SV, Dyment DA, Cader MZ, et al. Rare variants in the CYP27B1 gene are associated with multiple sclerosis. Ann Neurol 2011; 70:881-886.
32. Lucas RM, Ponsonby AL, Dear K, et al. Current and past Epstein-Barr virus infection in risk of initial CNS demyelination. Neurology 2011; 77:371-379.
33. Munger KL, Levin LI, O'Reilly EJ, et al. Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel. Mult Scler 2011; 17:1185-1193.
34. Mayne CG, Spanier JA, Relland LM, et al. 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. Eur J Immunol 2011; 41:822-832.
35. Meehan TF, DeLuca HF. The vitamin D receptor is necessary for 1alpha, 25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. Arch Biochem Biophys 2002; 408:200-204.
36. Na S, Ma Y, Zhao J, et al. A nonsecosteroidal vitamin D receptor modulator ameliorates experimental autoimmune encephalomyelitis without causing hypercalcemia. Autoimmune Dis 2011; 2011. doi:10.4061/2011/132958. [Epub ahead of print]
37. Sloka S, Silva C, Wang J, Yong VW. Predominance of Th2 polarization by vitaminDthrough aSTAT6-dependentmechanism. JNeuroinflamm2011; 8:56.
38. Spach KM, Hayes CE. Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 2005; 175:4119-4126.
39. Deluca HF, Plum LA. Vitamin D deficiency diminishes the severity and delays onset of experimental autoimmune encephalomyelitis. Arch Biochem Biophys 2011; 513:140-143.
40. Smolders J, Peelen E, Thewissen M, et al. Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis. PLoS One 2010; 5:e15235.
41. Kimball S, Vieth R, Dosch HM, et al. Cholecalciferol plus calcium suppresses abnormal PBMC reactivity in patients with multiple sclerosis. J Clin Endocrinol Metab 2011; 96:2826-2834.
42. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann Neurol 2007; 61:288-299.
43. Holmoy T. Vitamin D status modulates the immune response to Epstein Barr virus: synergistic effect of risk factors in multiple sclerosis. Med Hypotheses 2007; 70:66-69.
44. Hayes CE, Donald Acheson E. A unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10. Med Hypotheses 2008; 71:85-90.
45. Lysandropoulos AP, Jaquiery E, Jilek S, et al. Vitamin D has a direct immunomodulatory effect on CD8 + T cells of patients with early multiple sclerosis and healthy control subjects. J Neuroimmunol 2011; 233:240-244.
46. Lossius A, Vartdal F, Holmoy T. Vitamin D sensitive EBNA-1 specific T cells in the cerebrospinal fluid of patients with multiple sclerosis. J Neuroimmunol 2011; 240-241:87-96.
47. Correale J, Ysrraelit MC, Gaitan MI. Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain 2009; 132:1146-1160.
48. Provvedini DM, Manolagas SC. 1 Alpha,25-dihydroxyvitamin D3 receptor distribution and effects in subpopulations of normal human T lymphocytes. J Clin Endocrinol Metab 1989; 68:774-779.